AN2 Therapeutics (ANTX) Other Non-Current Assets (2022 - 2025)

AN2 Therapeutics (ANTX) has 4 years of Other Non-Current Assets data on file, last reported at $304000.0 in Q1 2025.

• On a quarterly basis, Other Non-Current Assets fell 70.85% year-over-year to $304000.0 in Q1 2025; TTM through Mar 2025 was $304000.0, a 70.85% decrease from a year earlier, with the FY2024 full-year figure at $804000.0, down 22.91% from the prior year.
• Other Non-Current Assets for Q1 2025 stood at $304000.0, down from $804000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for ANTX reached as high as $1.0 million in Q3 2023 and fell as low as $304000.0 in Q1 2025.
• Historically, Other Non-Current Assets has averaged $800000.0 across 4 years, with a median of $720000.0 in 2022.
• Across the five-year window, Other Non-Current Assets surged 44.86% in 2023 and plunged 70.85% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $720000.0 in 2022, then jumped by 44.86% to $1.0 million in 2023, then declined by 22.91% to $804000.0 in 2024, then sank by 62.19% to $304000.0 in 2025.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $304000.0 in Q1 2025, $804000.0 in Q4 2024, and $1.0 million in Q2 2024.